Sunnyvale, CA, United States of America

Julie Lee

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Julie Lee

Introduction

Julie Lee is a prominent inventor based in Sunnyvale, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled delivery systems for medications. Her work focuses on improving the efficacy and patient compliance of antipsychotic drugs.

Latest Patents

Julie Lee holds a patent for "Methods and dosage forms for controlled delivery of paliperidone and risperidone." This patent describes dosage forms and methods that provide a substantially ascending rate of release of paliperidone or risperidone. The sustained release dosage forms ensure therapeutically effective average steady-state plasma concentrations when administered once per day. This innovative dosing regimen results in only one peak plasma concentration occurrence within a 24-hour period, enhancing the overall treatment experience for patients.

Career Highlights

Throughout her career, Julie has been associated with Alza Corporation, where she has contributed to various projects aimed at advancing drug delivery technologies. Her expertise in pharmaceutical formulations has positioned her as a valuable asset in the industry.

Collaborations

Julie has worked alongside talented colleagues, including Nyomi V Yam and Iran Reyes, fostering a collaborative environment that encourages innovation and creativity in their projects.

Conclusion

Julie Lee's contributions to the field of pharmaceuticals through her innovative patent and collaborative efforts highlight her commitment to improving patient care. Her work continues to influence the development of effective medication delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…